AG00IBH9

65271-80-9 | 1,4-dihydroxy-5,8-bis[2-[(1,1,2,2-tetradeuterio-2-hydroxyethyl)amino]ethylamino]anthracene-9,10-dione

AG00IBH9

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	65271-80-9
Catalog Number	AG00IBH9(AGN-PC-07A243)
Chemical Name	1,4-dihydroxy-5,8-bis[2-[(1,1,2,2-tetradeuterio-2-hydroxyethyl)amino]ethylamino]anthracene-9,10-dione
IUPAC Name	1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione
InChI	InChI=1S/C22H28N4O6/c27-11-9-23-5-7-25-13-1-2-14(26-8-6-24-10-12-28)18-17(13)21(31)19-15(29)3-4-16(30)20(19)22(18)32/h1-4,23-30H,5-12H2
InChI Key	KKZJGLLVHKMTCM-UHFFFAOYSA-N
MDL Number	MFCD00242942
Molecular Formula	C22H28N4O6
Molecular Weight	444.4809
NSC Number	279836
SMILES	O=C1C2=C(C(NCCNCCO)=CC=C2NCCNCCO)C(C3=C(O)C=CC(O)=C13)=O
UNII	BZ114NVM5P
Synonyms	Acetate, Mitoxantrone, CL 232325, CL-232325, CL232325, DHAQ, Hydrochloride, Mitoxantrone, Mitoxantrone, Mitoxantrone Acetate, Mitoxantrone Hydrochloride, Mitozantrone, Mitroxone, Novantron, Novantrone, NSC 279836, NSC 287836, NSC 299195, NSC 301739, NSC 301739D, NSC-279836, NSC-287836, NSC-299195, NSC-301739, NSC-301739D, NSC279836, NSC287836, NSC299195, NSC301739, NSC301739D, Onkotrone, Pralifan, Ralenova, mitoxantrone, 65271-80-9, Mitoxanthrone, Mitozantrone, DHAQ, Dihydroxyanthraquinone, Mitoxantron, Novantrone, Mitoxantrona, Mitoxantronum, Mitoxantronum [INN-Latin], Mitoxantrona [INN-Spanish], Mitoxantrone [INN], NSC 279836, UNII-BZ114NVM5P, DHAD, NSC279836, Mitoxantrone (INN), CCRIS 7604, C22H28N4O6, NSC-279836, DHAQ HCl, BRN 2795126, BZ114NVM5P, 1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone, 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone, 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone, 1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione, 1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE, MLS002703044, 1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon, CHEBI:50729, KKZJGLLVHKMTCM-UHFFFAOYSA-N, 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione, NSC299195, NSC301739, NSC-299195, 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione, 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-, ANTHRAQUINONE, 5,8-BIS((2-((2-HYDROXYETHYL)AMINO)ETHYL)AMINO)-1,4-DIHYDROXY-, MIX, MLS001333711, Misostol (TN), 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-dihydroanthracene-9,10-dione, NCGC00015693-02, Mitoxantrone (free base), SMR000058480, Mitoxantrone [INN:BAN], CAS-70476-82-3, DHAQ (*Diacetate salt*), SR-01000076001, 2fum, 1,4-dihydroxy-5,8-bis(2-(2-hydroxyethylamino)ethylamino)anthracene-9,10-dione, 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthracene-9,10-dione, NSC-301739D, Immunex (Salt/Mix), NSC-287836, Spectrum_001655, Liposome Encapsulated Mitoxantrone (LEM), AC1L1HNY, CHEMBL58, Prestwick0_000385, Prestwick1_000385, Prestwick2_000385, Prestwick3_000385, Spectrum2_000908, Spectrum3_001590, Spectrum4_000866, Spectrum5_001205, Lopac-M-6545, cid_4212, Neuro_000153, SCHEMBL3000, BIDD:PXR0181, Lopac0_000779, BSPBio_000569, BSPBio_003160, KBioGR_001531, KBioSS_002135, AN-584/42007670, DivK1c_000516, SPBio_000756, SPBio_002490, BPBio1_000627, GTPL7242, Novantrone(R) (mitoxantrone for injection concentrate), DTXSID4046947, BDBM67690, cid_5458171, CTK8A5416, KBio1_000516, KBio2_002135, KBio2_004703, KBio2_007271, KBio3_002660, NINDS_000516, HMS2090D05, HMS3655E20, KUC108634N, BCP02861, EBD32557, ZINC3794794, CCG-36371, CM0184, s1889, STK631833, Mitoxantrone hydrochloride (Salt/Mix), AKOS005564036, API0003408, BCP9000931, CS-2524, DB01204, KSC-19-204, MCULE-5513787065, IDI1_000516, SMP2_000179, NCGC00015693-01, NCGC00015693-03, NCGC00015693-04, NCGC00015693-05, NCGC00015693-06, NCGC00015693-08, NCGC00162251-01, AK323601, AN-14761, AN-38696, AS-35321, BC651765, HY-13502, K061, LS-20638, MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE, MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE, NCI60_002276, NCI60_002535, SC-22733, SMR001549953, SY226320, SBI-0050757.P003, TX-017756, AB00053716, FT-0630752, SW196745-6, MFCD00242942 (95%), VU0244399-2, 71M809, C11195, D08224, 13181-EP2270008A1, 13181-EP2270505A1, 13181-EP2272827A1, 13181-EP2275420A1, 13181-EP2277876A1, 13181-EP2289892A1, 13181-EP2292617A1, 13181-EP2295055A2, 13181-EP2295412A1, 13181-EP2295413A1, 13181-EP2295416A2, 13181-EP2295426A1, 13181-EP2295427A1, 13181-EP2298748A2, 13181-EP2298764A1, 13181-EP2298765A1, 13181-EP2301928A1, 13181-EP2305642A2, 13181-EP2305660A1, 13181-EP2311453A1, 13181-EP2311808A1, 13181-EP2311829A1, 13181-EP2311837A1, 13181-EP2311840A1, 13181-EP2311842A2, 13181-EP2316832A1, 13181-EP2316833A1, 13181-EP2316834A1, AB00053716-18, AB00053716-19, AB00053716-22, AB00053716_23, AB00053716_24, SR-01000076001-7, BRD-K21680192-001-01-5, BRD-K21680192-001-11-4, BRD-K21680192-300-05-2, BRD-K21680192-300-07-8, BRD-K21680192-300-09-4, BRD-K21680192-300-10-2, BRD-K21680192-300-12-8, 1,4-bis[2-(2-hydroxyethylamino)-ethylamino]-5,8-dihydroxyanthraquinone, 1,4-bis[2-(2-hydroxyethylamino)ethylamino]-5,8-dihydroxyanthraquinone, 1,4-dihydroxy-5,8-bis[[2-(2-hydroxyethylamino)ethyl]amino]anthraquinone, 9, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl] amino]-, 1,4-Bis[[2-[(2-hydroxyethyl)amino]ethyl]imino]-1,4-dihydroanthracene-5,8,9,10-tetrol, 1,4-Dihydroxy-5,8-bis-[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthraquinone, 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]-9,10-anthraquinone;hydrochloride, 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]-anthracene-9,10-dione, 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;hydrochloride, 1,4-bis[2-(2-hydroxyethylamino)ethylamino]-5,8-bis(oxidanyl)anthracene-9,10-dione;hydrochloride, 1,4-dihydroxy-5,8-bis[2-[(1,1,2,2-tetradeuterio-2-hydroxyethyl)amino]ethylamino]anthracene-9,10-dione, 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)- (9CI), Mitozantrone|||Novantron|||CL-232325|||1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione, Novantron, Mitox, nimitoxantron, Mitoxantrone HCl, Misostol, Mitroxone, Onkotrone, Pralifan, Ralenova, Dhaq diacetate, Mitoxantrone 2HCl, Mitoxantrone hydrochloride, Novantrone (TN), Mitoxantrone Acetate, Acetate, Mitoxantrone, Mitoxantrone diacetate, Mitoxantrone dihydrochloride, Mitozantrone hydrochloride, D0R3JB, Hydrochloride, Mitoxantrone, CID4212, MITOXANTHRONE HYDROCHLORIDE, NSC301739D, NSC 299195, NSC-301739, NSC 301739D, NSC287836, C22H28N4O6.2C2H4O2, C22-H28-N4-O6, NSC 287836, NSC 301739, CL232325, CL 232325, CL-232315, CL-232325, 2590B, C22-H28-N4-O6.2C2-H4-O2, A10595, D008942, 1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione diacetate, 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone 1,4-diaceate, 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-(9CI), 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-, 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxy-9,10-anthracenedione diacetate, 70476-82-3, 70711-41-0, Anthraquinone, 5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxy-, 1,4-diacetate (salt),

Complexity	571
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	444.201g/mol
Formal Charge	0
Heavy Atom Count	32
Hydrogen Bond Acceptor Count	10
Hydrogen Bond Donor Count	8
Isotope Atom Count	0
Molecular Weight	444.488g/mol
Monoisotopic Mass	444.201g/mol
Rotatable Bond Count	12
Topological Polar Surface Area	163A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	1

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	\N
Hazard statements	H302
Packing Group	\N
Precautionary statements	P280-P305+P351+P338
UN Code	\N

Certificate of Analysis

Lot Number